CA2709132A1 - Facteurs hotes cibles pour le traitement d'une infection virale - Google Patents

Facteurs hotes cibles pour le traitement d'une infection virale Download PDF

Info

Publication number
CA2709132A1
CA2709132A1 CA2709132A CA2709132A CA2709132A1 CA 2709132 A1 CA2709132 A1 CA 2709132A1 CA 2709132 A CA2709132 A CA 2709132A CA 2709132 A CA2709132 A CA 2709132A CA 2709132 A1 CA2709132 A1 CA 2709132A1
Authority
CA
Canada
Prior art keywords
seq
tnfsf13
virus
shrna
bad
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2709132A
Other languages
English (en)
Inventor
Kevin M. Coombs
John Wilkins
Anh T. Tran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2709132A priority Critical patent/CA2709132A1/fr
Publication of CA2709132A1 publication Critical patent/CA2709132A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2709132A 2010-07-07 2010-07-07 Facteurs hotes cibles pour le traitement d'une infection virale Abandoned CA2709132A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2709132A CA2709132A1 (fr) 2010-07-07 2010-07-07 Facteurs hotes cibles pour le traitement d'une infection virale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2709132A CA2709132A1 (fr) 2010-07-07 2010-07-07 Facteurs hotes cibles pour le traitement d'une infection virale

Publications (1)

Publication Number Publication Date
CA2709132A1 true CA2709132A1 (fr) 2012-01-07

Family

ID=45442704

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2709132A Abandoned CA2709132A1 (fr) 2010-07-07 2010-07-07 Facteurs hotes cibles pour le traitement d'une infection virale

Country Status (1)

Country Link
CA (1) CA2709132A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10188695B2 (en) 2012-02-23 2019-01-29 Sensorion Calcineurin inhibitors for use in the treatment of lesional vestibular disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10188695B2 (en) 2012-02-23 2019-01-29 Sensorion Calcineurin inhibitors for use in the treatment of lesional vestibular disorders

Similar Documents

Publication Publication Date Title
Kong et al. BST2 suppresses porcine epidemic diarrhea virus replication by targeting and degrading virus nucleocapsid protein with selective autophagy
Sun et al. MicroRNA-20a regulates autophagy related protein-ATG16L1 in hypoxia-induced osteoclast differentiation
Chiang et al. Sequence-specific modifications enhance the broad-spectrum antiviral response activated by RIG-I agonists
US8933046B2 (en) Influenza targets
US8377901B2 (en) Target host factors for treating viral infection
Mayank et al. Nucleoprotein of influenza A virus negatively impacts antiapoptotic protein API5 to enhance E2F1-dependent apoptosis and virus replication
JP2010279385A (ja) インフルエンザウイルス感染を処置および検出するために有用な核酸分子、ポリペプチド、抗体、およびそれらを含有する組成物
Martin-Sancho et al. Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy
WO2011029914A1 (fr) Méthode pour la préparation d'un virus de la grippe
Spiropoulou et al. RIG-I activation inhibits ebolavirus replication
Sadewasser et al. Anti-Niemann Pick C1 single-stranded oligonucleotides with locked nucleic acids potently reduce Ebola virus infection in vitro
US9328347B2 (en) siRNA useful in the treatment of flavivirus infection
Lu et al. Human RNase3 immune modulation by catalytic-dependent and independent modes in a macrophage-cell line infection model
US20070087982A1 (en) Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences
Zheng et al. TRAF3 activates STING-mediated suppression of EV-A71 and target of viral evasion
JP2015096067A (ja) 熱非対称インターレース（ｔａｉｌ）ｐｃｒを用いたランダムホモ接合性遺伝子摂動（ｒｈｇｐ）
Narayan et al. Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo
Chen et al. Splicing factor SF3B3, a NS5-binding protein, restricts ZIKV infection by targeting GCH1
US10308938B2 (en) Compositions and methods to activate or inhibit toll-like receptor signaling
CA2709132A1 (fr) Facteurs hotes cibles pour le traitement d'une infection virale
US20220288087A1 (en) Pim1 inhibitors for use in treatment of viral infection and pharmaceutical compositions thereof
US20170137824A1 (en) New treatment against influenza virus
Reigada et al. Micro RNA‐135a‐5p reduces P2X7‐dependent rise in intracellular calcium and protects against excitotoxicity
US11266675B2 (en) Methods of treatment of viral infection and uses of anti-HSC70 inhibitors
US20220002400A1 (en) Methods of Treating Influenza A Virus Infections

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20160707